Jonathan Herskovitz
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 detection and testing
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Virology top 5%
- HIV Research and Treatment
Papers in
-
- SARS-CoV-2 and COVID-19 Research 4
- COVID-19 Clinical Research Studies 2
- HIV/AIDS drug development and treatment 2
-
- Nanoparticle-Based Drug Delivery 5
- Co-authors
- Howard Eliot Gendelman (15 shared papers)Bhavesh D. Kevadiya (11 shared papers)Jatin Machhi (10 shared papers)David G. Brooks (2 shared papers)Elizabeth B. Wilson (2 shared papers)Heidi J. Elsaesser (2 shared papers)Mahmudul Hasan (9 shared papers)Christopher L. Karp (1 shared paper)
- Journals
- Journal of Neuroimmune Pharmacology (4 papers)Biomaterials (3 papers)Journal of Controlled Release (1 paper)Oncotarget (1 paper)Journal of Neuroinflammation (1 paper)
- Partner nations
- United StatesIndiaChina
In The Last Decade
Jonathan Herskovitz
24 papers receiving 2.5k citations
Jonathan Herskovitz's Hit Papers
Peers
Comparison fields: 5 of 134
- Infectious Diseases 767
- Virology 130
- Immunology 569
- Neurology 118
- Pharmaceutical Science 68
Countries citing papers authored by Jonathan Herskovitz
This map shows the geographic impact of Jonathan Herskovitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Herskovitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Herskovitz more than expected).
Fields of papers citing papers by Jonathan Herskovitz
This network shows the impact of papers produced by Jonathan Herskovitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Herskovitz. The network helps show where Jonathan Herskovitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Herskovitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Diagnostics for SARS-CoV-2 infections Hit paper breakdown → | 2021 | 650 |
| 2 | Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection Hit paper breakdown → | 2013 | 614 |
| 3 | 2020 | 434 | |
| 4 | 2021 | 115 | |
| 5 | 2020 | 106 | |
| 6 | 2016 | 102 | |
| 7 | 2021 | 84 | |
| 8 | 2016 | 83 | |
| 9 | 2016 | 58 | |
| 10 | 2021 | 45 | |
| 11 | 2021 | 45 | |
| 12 | 2018 | 39 | |
| 13 | 2019 | 30 | |
| 14 | 2019 | 28 | |
| 15 | 2019 | 27 | |
| 16 | 2019 | 24 | |
| 17 | 2019 | 18 | |
| 18 | 2024 | 14 | |
| 19 | 2017 | 10 | |
| 20 | 2021 | 9 |
About Jonathan Herskovitz
Jonathan Herskovitz is a scholar working on Infectious Diseases, Biomaterials, Immunology, Pharmaceutical Science and Virology, having authored 25 papers that have together received 2.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Advanced Drug Delivery Systems (3 papers), Biosimilars and Bioanalytical Methods (3 papers), COVID-19 Clinical Research Studies (2 papers), Alzheimer's disease research and treatments (2 papers), HIV Research and Treatment (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Infectious Diseases (767 citations), Virology (130 citations), Immunology (569 citations), Neurology (118 citations) and Pharmaceutical Science (68 citations). Jonathan Herskovitz has collaborated with scholars based in United States, India and China. Frequent co-authors include Howard Eliot Gendelman, Bhavesh D. Kevadiya, Jatin Machhi, David G. Brooks, Elizabeth B. Wilson, Heidi J. Elsaesser, Mahmudul Hasan, Christopher L. Karp, Genhong Cheng and Douglas H. Yamada. Their work appears in journals such as Journal of Neuroimmune Pharmacology, Biomaterials, Journal of Controlled Release, Oncotarget and Journal of Neuroinflammation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.